Investors File Class Action Against Doximity Over Market Share Claims
A class action lawsuit filed against Doximity, Inc. alleges the digital medical platform misled shareholders about its competitive standing and revenue drivers. Plaintiffs claim the company concealed a loss of market share while publicly touting its Newsfeed as a primary growth engine between August 2024 and May 2026.

The complaint, filed by law firm Robbins LLP, asserts that Doximity executives overstated the impact of their Newsfeed product while failing to disclose that competitors offered more favorable pricing and engagement models. Despite claims that the company avoided intrusive advertising, the lawsuit alleges Doximity relied heavily on banner ads and email newsletters to maintain its reach.
Shareholder confidence eroded following a series of disclosures that triggered sharp stock price declines. On November 6, 2025, shares fell 13% after the company warned of slowing sales. Subsequent reports in February and May 2026 revealed decelerating growth and missed revenue targets, leading to further drops of 17% and 23%, respectively. Analysts at firms including Evercore and RBC Capital Markets pointed to an increasingly competitive environment, with some describing the company's performance as a significant setback. Investors who acquired stock during the period ending May 13, 2026, have until November 16, 2026, to apply for lead plaintiff status.
Comments (0)
No comments yet. Be the first!